Found: 34
Select item for more details and to access through your institution.
Corrigendum to 'Departments involved during the first episode of acute heart failure and analysis of emergency department revisits and rehospitalisations: an outlook through the NOVICA cohort' [Eur J Heart Fail 2019;21:1231-1244].
- Published in:
- 2020
- Publication type:
- corrected article
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure Association and the Cardio‐Oncology Council of the European Society of Cardiology
- Published in:
- 2020
- By:
- Publication type:
- journal article
Myocardial iron content in non‐ischaemic cardiomyopathy: how much is known?
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2047, doi. 10.1002/ejhf.2023
- By:
- Publication type:
- Article
Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC‐HF baseline characteristics and comparison with contemporary clinical trials.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2160, doi. 10.1002/ejhf.2015
- By:
- Publication type:
- Article
Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failure (an update on the sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effects of hyperkalaemia and non-adherence to renin-angiotensin-aldosterone system inhibitor therapy in patients with heart failure in Italy: a propensity-matched study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Figures of the Heart Failure Association: Prof. Lars H. Lund, Chair of the HFA Committee on Registries, Surveys and Epidemiology and HFA Board Member (from 2016).
- Published in:
- 2020
- By:
- Publication type:
- Biography
Ten lessons from the EMPEROR‐Reduced trial.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 1991, doi. 10.1002/ejhf.2009
- By:
- Publication type:
- Article
EMPEROR-Reduced: confirming sodium-glucose co-transporter 2 inhibitors as an essential treatment for patients with heart failure with reduced ejection fraction.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Depression and heart failure: the lonely comorbidity.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Learning together: insights from the first Heart Failure Association patient forum.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 1939, doi. 10.1002/ejhf.2013
- By:
- Publication type:
- Article
The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Sex‐based differences in biomarkers, health status, and reverse cardiac remodelling in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2018, doi. 10.1002/ejhf.2005
- By:
- Publication type:
- Article
Beating the bushes for biomarkers.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2075, doi. 10.1002/ejhf.2004
- By:
- Publication type:
- Article
Cancer therapy and the heart; the necessity to calibrate risk.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 1961, doi. 10.1002/ejhf.1999
- By:
- Publication type:
- Article
A combined bioinformatics, experimental and clinical approach to identify novel cardiac‐specific heart failure biomarkers: is Dickkopf‐3 (DKK3) a possible candidate?
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2065, doi. 10.1002/ejhf.1988
- By:
- Publication type:
- Article
Serum potassium in the PARADIGM‐HF trial.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2056, doi. 10.1002/ejhf.1987
- By:
- Publication type:
- Article
Serum uric acid, influence of sacubitril–valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON‐HF.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2093, doi. 10.1002/ejhf.1984
- By:
- Publication type:
- Article
DAPA‐HF: does dapagliflozin provide 'bang for your buck' as a treatment for heart failure with reduced ejection fraction?
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2157, doi. 10.1002/ejhf.1982
- By:
- Publication type:
- Article
In search of a 'safety zone' for glycaemic control: association between glycosylated haemoglobin levels and outcomes in patients with type 2 diabetes and cardiovascular disease.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2035, doi. 10.1002/ejhf.1981
- By:
- Publication type:
- Article
Cost‐effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health‐economic analysis of DAPA‐HF.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2147, doi. 10.1002/ejhf.1978
- By:
- Publication type:
- Article
Frailty and the failing heart do not travel alone.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2120, doi. 10.1002/ejhf.1973
- By:
- Publication type:
- Article
Association between glycated haemoglobin levels and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the TECOS randomized clinical trial.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2026, doi. 10.1002/ejhf.1958
- By:
- Publication type:
- Article
Pathogenesis and management of myocardial injury in coronavirus disease 2019.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 1994, doi. 10.1002/ejhf.1967
- By:
- Publication type:
- Article
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio‐Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio‐Oncology Society
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 1945, doi. 10.1002/ejhf.1920
- By:
- Publication type:
- Article
Prevalence and prognostic impact of the coexistence of multiple frailty domains in elderly patients with heart failure: the FRAGILE‐HF cohort study.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2112, doi. 10.1002/ejhf.1926
- By:
- Publication type:
- Article
<sup>18</sup> F-FDG PET/CT brain glucose metabolism as a marker of different types of depression comorbidity in chronic heart failure patients with impaired systolic function.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Assessing frailty in heart failure.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2134, doi. 10.1002/ejhf.1905
- By:
- Publication type:
- Article
Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N‐terminal pro‐B‐type natriuretic peptide and high‐sensitivity troponin T.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2078, doi. 10.1002/ejhf.1701
- By:
- Publication type:
- Article
Cardiac iron concentration in relation to systemic iron status and disease severity in non-ischaemic heart failure with reduced ejection fraction.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2102, doi. 10.1002/ejhf.1674
- By:
- Publication type:
- Article
Age and biomarkers in heart failure: challenging the current model to select patients for clinical trials.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
November 2020 at a glance: focus on comorbidities and medical treatment.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Issue Information.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. i, doi. 10.1002/ejhf.1962
- Publication type:
- Article